| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R W Kerwin, Sarah Osborne, Ricardo Sainz-Fuerte. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. Journal of psychopharmacology (Oxford, England). vol 18. issue 1. 2004-08-30. PMID:15107195. |
a case of heatstroke is reported in a 32-year-old man diagnosed with schizophrenia and on clozapine monotherapy. |
2004-08-30 |
2023-08-12 |
Not clear |
| Bruce J Kinon, Jonna Ahl, Virginia L Stauffer, Angela L Hill, Peter F Buckle. Dose response and atypical antipsychotics in schizophrenia. CNS drugs. vol 18. issue 9. 2004-08-23. PMID:15222776. |
limited data indicate that clozapine shows dose-related efficacy up to 600 mg/day in patients with treatment-resistant schizophrenia. |
2004-08-23 |
2023-08-12 |
Not clear |
| Ravi Kant, Ranjit Chalansani, K N Roy Chengappa, Mary F Dieringe. The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. Journal of child and adolescent psychopharmacology. vol 14. issue 1. 2004-08-17. PMID:15142392. |
there are limited data in the literature regarding clozapine use in adolescents with diagnoses other than schizophrenia. |
2004-08-17 |
2023-08-12 |
Not clear |
| Deanna L Kelly, Robert R Conley, Charles M Richardson, Carol A Tamminga, William T Carpente. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 15. issue 3-4. 2004-08-10. PMID:14971863. |
adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. |
2004-08-10 |
2023-08-12 |
Not clear |
| Deanna L Kelly, Robert R Conley, Charles M Richardson, Carol A Tamminga, William T Carpente. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 15. issue 3-4. 2004-08-10. PMID:14971863. |
patients with treatment-resistant schizophrenia pose a major challenge to caregivers since only clozapine is documented as having superior efficacy in this population. |
2004-08-10 |
2023-08-12 |
Not clear |
| Mathias Zink, Udo Knopf, Fritz A Henn, Johannes Thom. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. Pharmacopsychiatry. vol 37. issue 1. 2004-08-02. PMID:14750045. |
combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature. |
2004-08-02 |
2023-08-12 |
Not clear |
| I Reznik, I Yavin, R Stryjer, B Spivak, N Gonen, R Strous, R Mester, A Weizman, M Kotle. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry. vol 37. issue 2. 2004-08-02. PMID:15048611. |
clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. |
2004-08-02 |
2023-08-12 |
Not clear |
| Jean Mary Zarate, Patricia Boksa, Trino Baptista, Ridha Joobe. Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains. Psychopharmacology. vol 171. issue 2. 2004-07-27. PMID:14615871. |
effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains. |
2004-07-27 |
2023-08-12 |
mouse |
| Jean Mary Zarate, Patricia Boksa, Trino Baptista, Ridha Joobe. Effects of clozapine on behavioral and metabolic traits relevant for schizophrenia in two mouse strains. Psychopharmacology. vol 171. issue 2. 2004-07-27. PMID:14615871. |
in particular, patients with schizophrenia exhibit important variability in their therapeutic and metabolic responses to clozapine, an antipsychotic medication. |
2004-07-27 |
2023-08-12 |
mouse |
| Jari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, Eila Repo-Tiihonen, Irma Kotilainen, Markku Eronen, Päivi Toivonen, Kristian Wahlbeck, Anu Putkone. [Lamotrigine in clozapine treatment-resistant schizophrenia]. Duodecim; laaketieteellinen aikakauskirja. vol 120. issue 1. 2004-07-26. PMID:14976813. |
[lamotrigine in clozapine treatment-resistant schizophrenia]. |
2004-07-26 |
2023-08-12 |
Not clear |
| Andres Gross, Sirkka-Liisa Joutsiniemi, Ranan Rimon, Björn Appelber. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry. vol 37. issue 3. 2004-07-19. PMID:15138895. |
the changes of theta activity (3.5-7 hz) in the quantitative electroencephalography (qeeg) and serum clozapine levels and their correlation with clinical response, measured by the positive and negative syndrome rating scale (panss) for schizophrenia, were examined prospectively in 16 patients suffering from schizophrenia during 18 weeks of clozapine (clo) treatment. |
2004-07-19 |
2023-08-12 |
Not clear |
| Alessia S Maddalena, Mark Fox, Marc Hofmann, Christoph Hoc. Esophageal dysfunction on psychotropic medication. A case report and literature review. Pharmacopsychiatry. vol 37. issue 3. 2004-07-19. PMID:15138897. |
we report the association of long-term clozapine and clomipramine therapy with severe esophageal dilation and hypomotility in a patient with chronic schizophrenia leading to life threatening aspiration pneumonia. |
2004-07-19 |
2023-08-12 |
Not clear |
| Philip J Tyson, Kate H Roberts, Ann M Mortime. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? The International journal of neuroscience. vol 114. issue 6. 2004-07-19. PMID:15204055. |
forty-four patients with a dsm-iv diagnosis of schizophrenia were recruited within 6 weeks of starting one of the atypical antipsychotics: clozapine, olanzapine, risperidone, quetiapine, or amisulpride. |
2004-07-19 |
2023-08-12 |
Not clear |
| Carrie L Ernst, Joseph F Goldber. Antisuicide properties of psychotropic drugs: a critical review. Harvard review of psychiatry. vol 12. issue 1. 2004-07-15. PMID:14965852. |
nevertheless, an extensive literature has arisen regarding observed reductions in suicidal behavior with lithium for mood disorders and, to a lesser extent, with clozapine for schizophrenia. |
2004-07-15 |
2023-08-12 |
Not clear |
| John M Davis, Nancy Che. Dose response and dose equivalence of antipsychotics. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206667. |
doses of clozapine well above 400 mg are necessary for optimal treatment of many schizophrenia patients. |
2004-07-06 |
2023-08-12 |
Not clear |
| Jan Volavka, Pal Czobor, Karen Nolan, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P McEvoy, Thomas B Cooper, Jeffrey A Lieberma. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206671. |
overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. |
2004-07-06 |
2023-08-12 |
human |
| Rocco Zoccali, Maria Rosaria Muscatello, Clemente Cedro, Pietro Neri, Diletta La Torre, Edoardo Spina, Antonio Enrico Di Rosa, Mario Medur. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076014. |
the effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. |
2004-06-22 |
2023-08-12 |
Not clear |
| Rocco Zoccali, Maria Rosaria Muscatello, Clemente Cedro, Pietro Neri, Diletta La Torre, Edoardo Spina, Antonio Enrico Di Rosa, Mario Medur. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076014. |
this study was a 8-week double-blind, randomized, placebo-controlled trial of 30 mg adjunctive mirtazapine to clozapine therapy in 24 patients with dsm-iv schizophrenia. |
2004-06-22 |
2023-08-12 |
Not clear |
| Péter Gaszner, Zoltán Makko. Clozapine maintenance therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 3. 2004-06-17. PMID:15093952. |
clozapine maintenance therapy in schizophrenia. |
2004-06-17 |
2023-08-12 |
Not clear |
| Péter Gaszner, Zoltán Makko. Clozapine maintenance therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 3. 2004-06-17. PMID:15093952. |
records from over 1000 patients treated with clozapine during the past 22 years were examined; 782 of these patients were diagnosed with schizophrenia according to the diagnostic and statistical manual of mental disorders-fourth edition-text revision (dsm-iv-tr) criteria (with the modification in early years). |
2004-06-17 |
2023-08-12 |
Not clear |